Skip to content

Clinical Observation of Shen Ling Gujing Decoction in the treatment of Lifelong Premature Ejaculation with Syndrome of Heart and Gallbladder Qi deficiency

Clinical Observation of Shen Ling Gujing Decoction in the treatment of Lifelong Premature Ejaculation with Syndrome of Heart and Gallbladder Qi deficiency

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017282
Enrollment
Unknown
Registered
2018-07-20
Start date
2018-07-21
Completion date
Unknown
Last updated
2018-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lifelong Premature Ejaculation

Interventions

Test group:Shen Ling Gujing Decoction

Sponsors

Xiyuan Hospital, CACMS
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
22 Years to 50 Years

Inclusion criteria

Inclusion criteria: (1) the age of 22-50 years; (2) the course of disease was more than 6 months; (3) having a stable partner, the frequency of sexual life is more than 6 times / month. (4) conforming to the diagnostic standard of lifelong premature ejaculation, and the PEDT score is more than 11 points; (5) syndrome of heart and gallbladder Qi deficiency; (6) the signing of the informed consent.

Exclusion criteria

Exclusion criteria: (1) abnormal reproductive organs can not be sexually active; (2) urogenital tract infection, such as urethritis, bacterial prostatitis, etc.; (3) patients with erectile dysfunction had a IIEF-5 score of less than 21 points; (4) allergic constitution or allergy to any known drug in treatment; (5) patients with important organ diseases such as Yan Zhongxin, brain, kidney, liver, elevated intraocular pressure or risk of angle closure glaucoma; (6) moderate and severe depression patients, Hamilton Depression Scale (HAMD-17) score > 17 points; (7) moderate and severe anxiety patients, Hamilton Anxiety Scale (HAMA) score was more than 21 points; (8) taking drugs that might affect the efficacy within 4 weeks; (9) other clinical trials in 4 weeks; (10) there are childbearing planners in the last 6 months.

Design outcomes

Primary

MeasureTime frame
IELT;

Secondary

MeasureTime frame
PEP;CGIC;TCM syndrome score;

Countries

China

Contacts

Public ContactGuo Jun

Xiyuan Hospital of China Academy of Chinese Medical Sciences

guojun1126@126.com+86 010-62835134

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026